Skip to main content
Elizabeth Henske, MD, Oncology, Boston, MA

Elizabeth P Henske MD


Professor of Medicine at the Brigham and Women

Join to view full profile
  • 44 Binney StreetBoston, MA 02115

  • Phone+1 617-632-5320

  • Fax+1 215-214-1023

Dr. Henske is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1991
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1985 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1985

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1990 - 2027
  • PA State Medical License
    PA State Medical License 1996 - 2008
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2005

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Breakthrough in Chromophobe Renal Cancer Treatment
    Breakthrough in Chromophobe Renal Cancer TreatmentJuly 3rd, 2025
  • First Treatment for a Rare Form of Cancer Discovered
    First Treatment for a Rare Form of Cancer DiscoveredAugust 3rd, 2022
  • Novel Treatment for Rare Form of Kidney Cancer Uncovered
    Novel Treatment for Rare Form of Kidney Cancer UncoveredJune 21st, 2022

Grant Support

  • Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis ComplexBRIGHAM AND WOMEN'S HOSPITAL2023–2028
  • Role of TFEB and TFE3 in Tuberous Sclerosis Complex (TSC) Kidney DiseaseBRIGHAM AND WOMEN'S HOSPITAL2022–2026
  • Role of the Lysosome in the Pathogenesis and Therapy of LAMBRIGHAM AND WOMEN'S HOSPITAL2020–2025
  • The Molecular and Genetic Pathogenesis of LAMBRIGHAM AND WOMEN'S HOSPITAL2016–2025
  • Summit On Drug Discovery In Tuberous Sclerosis Complex And Related DisordersNational Institute Of Neurological Disorders And Stroke2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: